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Background
CaV1.4 L-type calcium channels show unique biophysi-
cal properties such as slow inactivation due to the lack
of calcium-dependent inactivation (CDI). These proper-
ties make CaV1.4 channels appropriate candidates for
triggering persistent glutamate release at retinal photo-
receptor cell synapses. Mutations in the CACNA1F gene
encoding for the CaV1.4 a1 subunit are described in
patients with X-linked congenital stationary night blind-
ness type 2 (CSNB2). Impaired transmission between
rod photoreceptor cells and second-order neurons mani-
fests as night blindness and various other visual symp-
toms in the affected individuals.
Methods
The aim of this study was to investigate the functional
properties of CaV1.4 mutants L849P and R1816stop
compared to wild-type (WT) in transiently transfected
tsA 201 cells (+b3,+a2δ-1) via whole-cell patch clamp
technique using 15 mM Ba2+ and Ca2+ as charge carrier.
For statistics, either Mann-Whitney (two groups) or
Kruskal-Wallis test and Dunn’s Post hoc test (multiple
comparisons) were used.
Results
L849P was mainly characterized by a reduced current den-
sity (pA/pF: WT: −16.3 ± 1.6 (n = 38), L849P: −2.5 ± 0.3
(n = 12), p < 0.0001; Ca2+), only minor, not significant
(p > 0.05) changes in the voltage-dependent activation
properties were observed. In presence of the dihydropyri-
din-activator BayK8644 (5 μM) the current density
was increased ~10-fold (p < 0.001). The fold-increase in
current density was comparable to WT. As expected
R1816stop, which lacks an intrinsic C-terminal modulator
(CTM), exhibited CDI (f-value: WT: 0.11 ± 0.03 (n = 8);
R1816stop: 0.63 ± 0.02 (n = 22)) and shifted the voltage-
dependence of activation to more negative voltages
(V0.5act in mV: WT: 1.8 ± 0.3 (n = 74), R1816stop:
−12.3 ± 0.3 (n = 23)). In presence of the CaV1.4-CTM;
comprising the last 122 C-terminal residues WT condi-
tions were fully restored, e.g. V0.5act 2.2 ± 1.0 mV (n = 14)
(p < 0.0001).
Conclusions
We assume that the reduced current density observed in
mutant L849P derives from decreased channel expression,
which might be explained by a folding defect of the
CaV1.4 channel protein rather than a reduced open prob-
ability. Moreover, the fact that the functional phenotype of
the R1816stop can be rescued bears a potential pharma-
cotherapeutic concept based to the C-terminal modulatory
mechanism present in CaV1.4 channels.
Acknowledgements
Financial support was given by the Austrian Science Fund (FWF, grant
P22526 to A.K.).
Author details
1Department of Neurophysiology and Neuropharmacology, Center for
Physiology and Pharmacology, Medical University of Vienna, 1090 Vienna,
* Correspondence: alexandra.koschak@meduniwien.ac.at
† Contributed equally
1Department of Neurophysiology and Neuropharmacology, Center for
Physiology and Pharmacology, Medical University of Vienna, 1090 Vienna,
Austria
Full list of author information is available at the end of the article
Schicker et al. BMC Pharmacology and Toxicology 2012, 13(Suppl 1):A69
http://www.biomedcentral.com/2050-6511/13/S1/A69
© 2012 Schicker et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
Austria. 2Department of Pharmacology and Toxicology, Institute of Pharmacy,
University of Innsbruck, 6020 Innsbruck, Austria.
Published: 17 September 2012
doi:10.1186/2050-6511-13-S1-A69
Cite this article as: Schicker et al.: Biophysical characterization of CaV1.4
L-type calcium channel mutants causing congenital stationary night
blindness type 2 in humans. BMC Pharmacology and Toxicology 2012
13(Suppl 1):A69.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Schicker et al. BMC Pharmacology and Toxicology 2012, 13(Suppl 1):A69
http://www.biomedcentral.com/2050-6511/13/S1/A69
Page 2 of 2
